The Nexomics patent portfolio provides proprietary
technology to enhance our service offerings as well
as support novel drug target validation.
Nexomics leverages its expertise in protein biochemistry,
nuclear magnetic resonance (NMR) and xray crystallography
to aid its customers discovery efforts.
12/22/08 Nexomics and Rutgers University Enter into license agreement
Nexomics Biosciences and Rutgers, the State University
of New Jersey have entered into an agreement giving
Nexomics rights to important intellectual property.
Protein Services Our Chaperone Enhanced E.Coli Expression Strains increase success in producing soluble protein.